AK6 and acute myeloid leukemia: These results are consistent with the survival analysis of our AML PDX mice model, supporting the hypothesis that lower expression of hCINAP in AML may confer higher error-prone NHEJ repair efficiency and lower error-free HR repair efficiency, to increase the sensitivity to DNR chemotherapy or radiotherapy.